← All organizations

Neurim Pharmaceuticals Ltd.

For profitWebsite ↗

Also known as: Neurim Pharmaceutical Ltd. | Neurim Pharmaceuticals Ltd.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

May 31, 2022

Timeline

1990s

Jun 1, 1991
Neurim Pharmaceuticals Ltd.— Founded

Drugs by trial phase (4 distinct, 17 trials)

Phase 4 (2 own, 0 via acquisition)

Phase 3 (1 own, 0 via acquisition)

piromelatine

Phase 2 (1 own, 0 via acquisition)

neu-120

Indications

Studied for

Recent trials (18)

NCT05267535Lead sponsorPhase 2/Phase 3May 31, 2022
NCT04233502Lead sponsorPhase 3Sep 30, 2020
NCT02615002Lead sponsorPhase 2Nov 1, 2015
NCT01906866Lead sponsorPhase 3Oct 1, 2013
NCT02087722CollaboratorPhase 3Aug 1, 2013
NCT01903681Lead sponsorPhase 1Mar 1, 2013
NCT01489969Lead sponsorPhase 2Dec 1, 2011
NCT01450228CollaboratorPhase 3Mar 1, 2011
NCT01280734Lead sponsorPhase 4Jan 1, 2011
NCT01114126Lead sponsorPhase 1Apr 1, 2010
NCT00940589Lead sponsorPhase 2Sep 1, 2009
NCT00607451Lead sponsorPhase 1/Phase 2Mar 1, 2008
NCT00607451Study directorPhase 1/Phase 2Mar 1, 2008
NCT00544791CollaboratorPhase 2Oct 1, 2007
NCT00397189Lead sponsorPhase 3Oct 1, 2006

Details

Founded: Tel Aviv, IL Jun 1, 1991
Last known activity: May 31, 2022